KR100899556B1 - Functional Foods Adding Sargassum spp. Extracts - Google Patents
Functional Foods Adding Sargassum spp. Extracts Download PDFInfo
- Publication number
- KR100899556B1 KR100899556B1 KR1020070111471A KR20070111471A KR100899556B1 KR 100899556 B1 KR100899556 B1 KR 100899556B1 KR 1020070111471 A KR1020070111471 A KR 1020070111471A KR 20070111471 A KR20070111471 A KR 20070111471A KR 100899556 B1 KR100899556 B1 KR 100899556B1
- Authority
- KR
- South Korea
- Prior art keywords
- added
- mother
- calcium
- extract
- functional food
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 34
- 235000013376 functional food Nutrition 0.000 title claims abstract description 29
- 241000195474 Sargassum Species 0.000 title description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 98
- 239000011575 calcium Substances 0.000 claims abstract description 97
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 97
- 238000010521 absorption reaction Methods 0.000 claims abstract description 60
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 26
- 235000008429 bread Nutrition 0.000 claims description 23
- 235000013618 yogurt Nutrition 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 14
- 235000014655 lactic acid Nutrition 0.000 claims description 13
- 239000004310 lactic acid Substances 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 9
- 235000013373 food additive Nutrition 0.000 claims description 8
- 239000002778 food additive Substances 0.000 claims description 8
- 238000000855 fermentation Methods 0.000 claims description 7
- 230000004151 fermentation Effects 0.000 claims description 7
- 235000013305 food Nutrition 0.000 claims description 7
- 239000002671 adjuvant Substances 0.000 claims description 6
- 239000008213 purified water Substances 0.000 claims description 6
- 235000015895 biscuits Nutrition 0.000 claims description 5
- 235000015218 chewing gum Nutrition 0.000 claims description 5
- 229940112822 chewing gum Drugs 0.000 claims description 5
- 235000019219 chocolate Nutrition 0.000 claims description 5
- 235000009508 confectionery Nutrition 0.000 claims description 5
- 235000015243 ice cream Nutrition 0.000 claims description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 4
- 235000013361 beverage Nutrition 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 claims description 3
- 229920000858 Cyclodextrin Polymers 0.000 claims description 3
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 3
- 235000019983 sodium metaphosphate Nutrition 0.000 claims description 3
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 235000020191 long-life milk Nutrition 0.000 claims 1
- 235000013402 health food Nutrition 0.000 abstract description 5
- 241000700159 Rattus Species 0.000 description 13
- 210000000988 bone and bone Anatomy 0.000 description 12
- 238000002360 preparation method Methods 0.000 description 11
- 229910052500 inorganic mineral Inorganic materials 0.000 description 9
- 239000011707 mineral Substances 0.000 description 9
- 235000010755 mineral Nutrition 0.000 description 9
- 235000019786 weight gain Nutrition 0.000 description 8
- 230000004584 weight gain Effects 0.000 description 7
- 244000299461 Theobroma cacao Species 0.000 description 6
- 230000008468 bone growth Effects 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 238000007796 conventional method Methods 0.000 description 6
- 241001474374 Blennius Species 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 230000037118 bone strength Effects 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 235000021050 feed intake Nutrition 0.000 description 4
- 230000008774 maternal effect Effects 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 3
- 230000037182 bone density Effects 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- -1 1994 Substances 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 235000009470 Theobroma cacao Nutrition 0.000 description 2
- CPGKMLVTFNUAHL-UHFFFAOYSA-N [Ca].[Ca] Chemical compound [Ca].[Ca] CPGKMLVTFNUAHL-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 208000007442 rickets Diseases 0.000 description 2
- 230000005070 ripening Effects 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 229950003429 sorbitan palmitate Drugs 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 241000272517 Anseriformes Species 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 208000003217 Tetany Diseases 0.000 description 1
- 244000290333 Vanilla fragrans Species 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002956 ash Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000004097 bone metabolism Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 230000003913 calcium metabolism Effects 0.000 description 1
- 229940069978 calcium supplement Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 210000003278 egg shell Anatomy 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000013861 fat-free Nutrition 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000010198 maturation time Effects 0.000 description 1
- 235000021243 milk fat Nutrition 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 230000036640 muscle relaxation Effects 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 239000007968 orange flavor Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- YXJHJCDOUFKMBG-BMZHGHOISA-M riboflavin sodium Chemical compound [Na+].OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)[N-]C2=O YXJHJCDOUFKMBG-BMZHGHOISA-M 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/20—Synthetic spices, flavouring agents or condiments
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/40—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by drying or kilning; Subsequent reconstitution
- A23L3/44—Freeze-drying
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/14—Yeasts or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/15—Inorganic Compounds
- A23V2250/156—Mineral combination
- A23V2250/1578—Calcium
Abstract
본 발명은 모자반 추출물을 첨가한 기능성 식품에 관한 것으로서, 보다 상세하게는 모자반 추출물에서 얻어진 칼슘흡수 보조제를 첨가한 기능성 식품에 관한 것이다. 본 발명의 기능성 식품은 다양한 종류의 건강식품으로 인체에 부족하기 쉬운 다량의 칼슘을 제공하므로, 우리나라 성인에게 부족한 칼슘을 보충하도록 사용될 수 있다.The present invention relates to a functional food to which the mother and child extract is added, and more particularly, to a functional food to which the calcium absorption aid obtained from the mother and child extract is added. The functional food of the present invention provides a large amount of calcium that is easy to lack in the human body as a variety of health food, it can be used to replenish calcium lacking in adults in Korea.
칼슘흡수, 모자반, 기능성 식품 Calcium absorption, mother board, functional food
Description
본 발명은 모자반 추출물을 첨가한 기능성 식품에 관한 것이다.The present invention relates to a functional food to which the mother and child extract is added.
해조에는 다량의 탄수화물과 각종 미네랄이 들어있다. 특히, 탄수화물은 대부분 비소화성 식이섬유로서 그 가치가 인정되어 많은 연구가 진행되고 있으며, 칼슘, 마그네슘, 요오드, 철, 아연 ,망간 등의 각종 미네랄이 존재한다고 알려져 있다(도정룡, 김은미, 구재근, 조길석, 1997, 국내산 주요 해조류의 식이섬유소의 함량 및 추출조건, 한국수산학회, 30(2), 291-296 ; P.Ruperez, 2002, Mineral content of edible marine seaweeds, Food chemistry, 79, 23-26). 하지만, 우리나라에서 해조는 식품소재로서 가공기술개발의 미흡으로 인하여 주로 부식개념으로 한정되어 쌀의 소비 감소와 더불어 감소하는 추세이다.Seaweed contains a large amount of carbohydrates and various minerals. In particular, carbohydrates are mostly non-digestible dietary fiber, the value of which has been recognized, many studies are being conducted, and it is known that various minerals such as calcium, magnesium, iodine, iron, zinc, manganese, etc. , 1997, Dietary Fiber Contents and Extraction Conditions of Major Korean Seaweeds, Korean Fisheries Society, 30 (2), 291-296; P.Ruperez, 2002, Mineral content of edible marine seaweeds, Food chemistry, 79, 23-26) . However, in Korea, seaweed is mainly limited to the concept of corrosion due to the lack of processing technology development as a food material, which is decreasing with the consumption of rice.
한편, 칼슘은 인체에 가장 많이 존재하는 무기질 원소로 일반 성인의 경우 체중의 약 2%인 1,200 g정도를 체내에 보유하고 있으며, 체내 칼슘의 99%는 골격과 치아를 형성하고 있고, 나머지 1%정도 만이 근육의 수축과 이완, 규칙적 심장박동, 혈액응고, 효소의 활성화, 세포 내 자극 및 흥분의 전달과 같은 생리활성 조절기능을 담당하고 있다(Einhorn, T.A., B.Levine and P.Michel, 1990, Nutrition and bone, Ortho.Clin.Nor.Am.,21, 43-50 ; Allen,L.H. and R.J. Wood, 1994, Calcium and Phosphours. In:Shil M.E.,J.A.Olson, M.shike eds:In Modem Nutrition in Health and Diease.8th.ed., 144-163). 이처럼 여러 가지 체내 조절기능을 담당하고 있는 혈청 내 칼슘의 농도는 10 ㎎/㎗ 전후로 항상 일정하게 유지되고 있으며, 칼슘의 공급이 장기간 결핍되게 되면 골격과 치아로부터 칼슘이 빠져나와 골다공증(osteoporosis), 구루병(rickets), 테타니(tetany)와 같은 결핍증이 유발되고, 그에 따라 칼슘농도가 낮아진 뼈는 골절이 되기 쉽다(Scalmati,A., M.Lipkin and H.Newmark, 1992, Calcium, vitamin D, and Colon cancer. In:Chemoff,R,R.P.Heaney ed.:Clinics in Applied Nutrition, Andover Med., 67-74 ; McCarren,D.A, 1997, Role of adequate dietary calcium intake in the prevention and management of salt-selective hypertension, Am.J.Clin.Nutr., 65, 712-716 ; Chung,H.K.,N.S.Chang, H.S. Lee and Y.E.Chang, 1996, The effects of various types of calcium and bone metabolism in rats, Kor.J.Nutr., 29, 480-488).On the other hand, calcium is the most abundant mineral in the human body and has about 1,200 g of body weight, about 2% of the average adult, and 99% of the body's calcium forms skeleton and teeth, and the remaining 1% Only to the extent they are responsible for regulating physiological activities such as muscle contraction and relaxation, regular heartbeats, blood coagulation, enzyme activation, intracellular stimulation and excitatory transmission (Einhorn, TA, B.Levine and P.Michel, 1990). , Nutrition and bone, Ortho. Clin. Nor. Am., 21, 43-50; Allen, LH and RJ Wood, 1994, Calcium and Phosphours.In:Shil ME, JAOlson, M. shike eds: In Modem Nutrition in Health and Diease. 8th.ed., 144-163). As such, the concentration of calcium in the serum, which is responsible for various body control functions, is always maintained around 10 mg / ㎗, and when calcium supply is deficient for a long time, calcium is released from the skeleton and teeth, osteoporosis and rickets. deficiencies such as rickets and tetany cause bones with low calcium levels to become fractures (Scalmati, A., M. Lipkin and H. Newmark, 1992, Calcium, vitamin D, and Colon) cancer.In: Chemoff, R, RP Heaney ed .: Clinics in Applied Nutrition, Andover Med., 67-74; McCarren, DA, 1997, Role of adequate dietary calcium intake in the prevention and management of salt-selective hypertension, Am J. Clin. Nutr., 65, 712-716; Chung, HK, NSChang, HS Lee and YEChang, 1996, The effects of various types of calcium and bone metabolism in rats, Kor. J. Nutr., 29 , 480-488).
음식으로부터 섭취된 칼슘은 장에서 흡수되나 그 흡수율은 비교적 낮으며, 칼슘의 존재 형태, 섭취량 및 비타민 등 기타의 식이 인자에 의하여 영향을 받으며 최근에는 미량 미네랄이 칼슘흡수에 관여 한다 보고된 바 있다(Allen,L.H. and R.J. Wood, 1994, Calcium and Phosphours. In:Shil M.E.,J.A.Olson, M.shike eds:In Modem Nutrition in Health and Diease.8th.ed., 144-163). 우리나라의 식이에서 칼슘의 흡수율은 12~46% 정도로 보고되고 있으며, 일반적으로 섭취량의 20~80% 가량이 대변으로 배설되는 것으로 알려져 있다. 최근 우리나라의 성인들이 식사를 통해 섭취하는 1일 칼슘 평균량은 511 ㎎으로 1일 권장량 700 ㎎에 미치지 못하고 있으므로, 칼슘 보충제에 대한 관심과 소비가 점차 증가하고 있는 추세이다.Calcium taken from food is absorbed by the intestine, but its absorption rate is relatively low, and is influenced by the presence of calcium, intake and other dietary factors such as vitamins, and recently trace minerals are involved in calcium absorption. Allen, LH and RJ Wood, 1994, Calcium and Phosphours.In:Shil ME, JAOlson, M. shike eds: In Modem Nutrition in Health and Diease. 8th.ed., 144-163). The absorption rate of calcium in the diet of Korea is reported to be 12 ~ 46%, and it is generally known that about 20 to 80% of the intake is excreted in feces. Recently, the average daily calcium intake by adults in Korea is 511 mg, which is less than the recommended daily amount of 700 mg, so the interest and consumption of calcium supplements is gradually increasing.
현재 유통되고 있는 칼슘은 대부분이 탄산칼슘이나 인산칼슘의 형태인 우골칼슘, 난각칼슘, 패각칼슘, 산호칼슘, 아쿠아칼슘 등이 있으나, 광우병 사태 이후에 육상동물 유래 칼슘에 대한 소비자의 거부감으로 인해 현재는 해양유래 칼슘이 많이 이용되고 있다.Currently, most of the calcium in circulation includes calcium carbonate or calcium phosphate, bovine calcium, eggshell calcium, shell calcium, coral calcium, aqua calcium, etc.But after the mad cow disease, consumer's rejection of terrestrial animal-derived calcium The marine-derived calcium is used a lot.
괭생이모자반(Sargussum Horneri)은 우리나아 동남 해안과 일본 해안의 청정 해역에서 서식하고, 해조류 갈조류 갈조식물문 이형세대강 원포자강 모자반목 모자반과에 속하는 1년생 해조이다. 괭생이모자반은 그 뿌리가 비교적 작은 가반상근(假盤狀根)이며 그 중심에서 원극상의 줄기가 나오고 줄기의 측면에서 가지가 나온다. 괭생이모자반에는 덱스트로스(dextrose), 조(粗)단백질, 순(純)단백질, 조(粗)섬유, 지방, 회분(ash), 무기질(칼슘, 인, 철 등을 포함함), 아미노산 등이 함 유되어 있다고 보고된 바 있다. 또한, 괭생이모자반은 닭, 오리 등의 사육을 위한 사료로 이용되어 왔다.Sargussum Horneri is a year-old seaweed that lives in the clean waters of the southeast and Japanese coasts of our country, and belongs to the algae brown algae brown algae vegetation heteromorphic river Wonpoja River maternity hat family. Hokkae mamopan is relatively small root, and its roots come out from the center and come out from the side of the stem. Auxiliary mother's bed includes dextrose, crude protein, pure protein, crude fiber, fat, ash, minerals (including calcium, phosphorus, iron), amino acids, etc. It has been reported to be included. In addition, the hoesaengban mother has been used as a feed for breeding chickens, ducks and the like.
이에, 본 발명자들은 칼슘흡수를 도와 줄 수 있는 건강식품을 개발하고자 노력하던 중, 괭생이모자반 추출물을 주성분으로 한 칼슘흡수 보조제를 개발하고 이를 이용한 다양한 기능성 식품을 제조하고 그 효능을 테스트함으로써 본 발명을 완성하였다.Therefore, the inventors of the present invention, while trying to develop a health food that can help the absorption of calcium, the present invention by developing a calcium absorption adjuvant based on the extract of boksaeng majaban, preparing various functional foods using the same and testing its efficacy Was completed.
본 발명의 목적은 모자반 추출물을 첨가한 기능성 식품을 제공하는 것이다.An object of the present invention is to provide a functional food to which the mother and child extract is added.
본 발명은 모자반 추출물에서 얻어진 칼슘흡수 보조제를 첨가한 기능성 식품을 제공한다.The present invention provides a functional food to which the calcium absorption aid obtained from the mother extract is added.
본 발명의 기능성 식품은 다양한 종류의 건강식품으로 인체에 부족하기 쉬운 다량의 칼슘을 제공하므로, 우리나라 성인에게 부족한 칼슘을 보충하도록 사용될 수 있다.The functional food of the present invention provides a large amount of calcium that is easy to lack in the human body as a variety of health food, it can be used to replenish calcium lacking in adults in Korea.
본 발명은 모자반 추출물에서 얻어진 칼슘흡수 보조제를 첨가한 기능성 식품을 제공한다.The present invention provides a functional food to which the calcium absorption aid obtained from the mother extract is added.
이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명의 기능성 식품에 있어서, 상기 기능성 식품은 요구르트, 식빵, 음료, 츄잉껌, 캔디, 비스켓, 아이스크림 및 초코렛으로 이루어진 군중에서 선택된 식품인 것이 바람직하고, 요구르트 또는 식빵인 것이 보다 바람직하다.In the functional food of the present invention, the functional food is preferably a food selected from the group consisting of yogurt, bread, beverage, chewing gum, candy, biscuits, ice cream and chocolate, and more preferably yogurt or bread.
또한, 본 발명의 기능성 식품에 있어서, 상기 모자반은 괭생이모자반인 것이 바람직하다.In addition, in the functional food of the present invention, the mother and child are preferably a mother-child group.
또한, 본 발명의 기능성 식품에 있어서, 상기 요구르트는 살균한 우유에 모자반 추출물에서 얻어진 칼슘흡수 보조제를 첨가하고 요구르트 혼합종균을 넣어 발효시켜 제조되는 것이 바람직하고, 상기 식빵은 이스트를 함유한 식빵믹스에 모자반 추출물에서 얻어진 칼슘흡수 보조제를 첨가하고 발효시켜 제조되는 것이 바람직하다.In addition, in the functional food of the present invention, the yogurt is preferably prepared by adding the calcium absorption aid obtained from the mother and child extract to fermented milk and fermenting the yogurt mixed spawn, and the bread is in the bread mix containing yeast It is preferably prepared by adding and fermenting the calcium absorption aid obtained from the mother extract.
또한, 본 발명의 기능성 식품에 있어서, 상기 칼슘흡수 보조제는 기능성 식품의 0.1 내지 2%(w/w)로 첨가되는 것이 바람직하고, ⅰ) 모자반을 건조한 후 파쇄하는 단계; ⅱ) 상기 파쇄된 모자반에 정제수 및 젖산을 첨가하여 혼합하는 단계; ⅲ) 상기 혼합물질을 여과하여 모자반을 추출하는 단계; 및 ⅳ) 상기 추출물에 식 품첨가물을 첨가하고, 이를 동결건조 및 분쇄하는 단계를 포함하는 것이 보다 바람직하고, 상기 정제수는 모자반의 100 질량부에 대하여 1000 내지 3000 질량부(w/w)를, 상기 젖산은 모자반 추출물 100 질량부에 대하여 0.001 내지 0.1 질량부(w/w)로 첨가하는 것이 더더욱 바람직하며, 상기 식품첨가물은 소듐메타포스페이트, 소르비탄말미테이트, 사이클로덱스트린 및 덱스트린인 것이 가장 바람직하다.In addition, in the functional food of the present invention, the calcium absorption aid is preferably added in 0.1 to 2% (w / w) of the functional food, iii) drying and crushing the mother board; Ii) adding purified water and lactic acid to the crushed mother board; Iii) filtering the mixture to extract hatban; And iii) adding a food additive to the extract, and lyophilizing and pulverizing it, wherein the purified water is 1000 to 3000 parts by mass (w / w) based on 100 parts by mass of the mother board, The lactic acid is more preferably added in an amount of 0.001 to 0.1 parts by mass (w / w) based on 100 parts by mass of Mabanban extract, and the food additive is most preferably sodium metaphosphate, sorbitan malmitate, cyclodextrin, and dextrin. .
본 발명자들은 모자반 추출물을 이용한 칼슘흡수 보조제를 제조하였다(도 1 참조). 구체적으로, 모자반을 건조하여 파쇄한 다음 정제수와 젖산용액을 첨가하여 고온에서 24시간동안 추출하였다. 상기 추출물을 여과하고 당도 20 brix가 될 때까지 농축하였다. 여기에 식품첨가물(표 1 참조)을 첨가하고 진공 동결 건조 및 분쇄하여 칼슘흡수 보조제를 완성하였다.The present inventors prepared a calcium absorption adjuvant using the Maban extract (see Fig. 1). Specifically, the mother board was dried and crushed, and then purified water and lactic acid solution were added and extracted at high temperature for 24 hours. The extract was filtered and concentrated to 20 brix of sugar. Food additives (see Table 1) were added thereto, vacuum freeze-dried and milled to complete the calcium absorption aid.
본 발명자들은 흰쥐를 이용하여 상기 방법으로 제조한 칼슘흡수 보조제의 효과를 테스트 하였다. 구체적으로, 흰쥐에 일반조제 사료를 섭취한 대조군, 일반조제 사료에 패각칼슘과 아쿠아칼슘을 첨가한 실험군, 일반조제사료에 본 발명의 모자반 칼슘흡수 보조제 첨가한 실험군, 및 일반조제 사료에 모자반 칼슘흡수 보조제와 패각칼슘, 아쿠아칼슘을 참가한 실험군을 대상으로 각각 사육한 후, 사료섭취량, 체중증가량, 뼈의 밀도, 강도, 성장정도를 측정하였다(표 2 내지 표 6 참조).The present inventors tested the effect of calcium absorption aid prepared by the above method using a rat. Specifically, the control group ingested the general diet for rats, the experimental group to which shell calcium and aqua calcium were added to the general formula, the experimental group to which the mother calcium absorption aid of the present invention was added to the general formula, and the mother calcium absorption to the general formula After feeding the supplements, shell calcium, and aqua calcium, the experimental groups were fed, respectively, and then the feed intake, weight gain, bone density, strength, and growth rate were measured (see Tables 2 to 6).
그 결과, 사료의 섭취량은 각 실험군에 유의적인 차이가 없어 대조군과 비교시 사료기피 현상은 나타나지 않았고, 총체중증가량 역시 유의적인 차이가 나타나지 않았다. 또한, 뼈의 성장을 나타내는 뼈의 습중량(wet weight), 길이, 직경 모 두 실험군 간에 유의적인 차이가 나타나지 않았다. 그러나, 뼈의 밀도와 강도에서는 모자반 칼슘흡수 보조제를 첨가 실험군이 대조군 및 다른 실험군보다 유의적으로 높게 나타났다. 이것은 본 발명의 칼슘흡수 보조제가 흰쥐의 칼슘흡수율을 높여 뼈성장에 도움을 주었기 때문이다(표 6 참조).As a result, there was no significant difference in feed intake between the experimental groups, so there was no avoidance of feed compared to the control group, and there was no significant difference in total weight gain. In addition, the wet weight, length, and diameter of the bones indicating the growth of the bones did not show a significant difference between the experimental groups. However, in the density and strength of bone, the experimental group added with maban calcium absorption aid was significantly higher than the control group and other experimental groups. This is because the calcium absorption aid of the present invention helped bone growth by increasing the calcium absorption rate of rats (see Table 6).
또한, 본 발명자들은 상기 방법으로 제조된 모자반 추출물을 이용한 칼슘흡수 보조제를 사용하여 다양한 기능성 식품을 제조하였다. 구체적으로, 우유를 살균하고 상기 칼슘흡수 보조제를 첨가하고 요구르트 혼합종균을 넣어 요구르트를 제조하고, 제조과정(숙성)중의 pH, 적정산도, 젖산균수의 변화를 측정하고 완제품의 관능검사를 실시하였다(도 2 내지 도 4). 그 결과, 각각 0.1%, 0.5%, 1% 모자반 칼슘흡수 보조제가 첨가된 경우, 그 첨가량이 증가할수록 발효과정에서 pH가 신속히 낮아졌으며, 적정산도 역시 그 첨가량이 증가할수록 발효과정에서 산도가 신속히 증가하였다. 아울러, 젖산균수는 모자반 칼슘흡수 보조제의 첨가량이 증가할수록 발효시간이 경과함에 따라 그 균수가 크게 증가하였다. 상기 결과는 모자반 칼슘흡수 보조제를 첨가할 경우 젖산균주의 증식을 활발하게 하여 숙성시간이 단축되는 것으로 나타났다.In addition, the present inventors prepared a variety of functional food using a calcium absorption aid using the mother-child extract prepared by the above method. Specifically, the milk was sterilized, the calcium absorption aid was added and the yogurt mixed spawn was added to prepare yogurt, the pH, titratable acidity, and the number of lactic acid bacteria were measured during the manufacturing process (aging), and the sensory test of the finished product was conducted ( 2 to 4). As a result, when 0.1%, 0.5%, and 1% maban calcium absorption aids were added, the pH of the fermentation process was rapidly lowered as the amount added, and the acidity increased rapidly during fermentation with the addition of the titratable acidity. It was. In addition, the number of lactic acid bacteria increased significantly as the fermentation time increased as the amount of mother calcium absorption aid increased. The results show that when the mother calcium absorption aid is added, the maturation time is shortened by actively proliferating the lactic acid strain.
또한, 식빵믹스에 상기 칼슘흡수 보조제를 첨가한 후 식빵을 제조하고, 각 제조된 빵의 크기를 살펴보았다(표 7 및 도 5 참조). 그 결과, 각각 0%, 0.5%, 1%, 2% 모자반 칼슘흡수 보조제가 첨가된 경우, 빵의 둘레와 무게는 첨가량에 의존하지 않고 비슷하지만 그 첨가량이 증가할수록 길이가 점차 증가하였다. 이는 모 자반 칼슘흡수 보조제가 이스트의 숙성에 긍정적인 영향을 주어 빵의 크기를 증대시킨다. In addition, after adding the calcium absorption aid to the bread mix to prepare a bread, and looked at the size of each prepared bread (see Table 7 and Figure 5). As a result, when 0%, 0.5%, 1%, and 2% mother calcium absorption aids were added, the breadth and weight of the bread were similar regardless of the amount added, but the length gradually increased as the amount added. This increases the size of the bread by the mother calcium absorption aid positively affects the yeast ripening.
이외에, 본 발명자들은 모자반 추출물을 이용한 칼슘흡수 보조제를 이용하여 음료, 츄잉껌, 캔디, 비스켓, 아이스크림 및 초코렛과 같은 다양한 건강식품을 제조하였다.In addition, the present inventors prepared various health foods such as beverages, chewing gum, candy, biscuits, ice cream and chocolate using calcium absorption aids using mabanban extract.
이하, 본 발명을 하기의 실시예에 의해 상세히 설명한다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예에 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail by the following examples. However, the following examples are merely to illustrate the invention, but the content of the present invention is not limited to the following examples.
<실시예 1><Example 1> 모자반을 이용한 칼슘흡수 보조제의 제조Preparation of calcium absorption aid using mother board
본 발명자들은 도 1에 기재된 바와 같이, 괭생이모자반을 건조하여 파쇄한 다음 20배 가량의 정제수와 원료의 건물량 0.02%(w/w)에 해당하는 젖산용액을 첨가하여 90℃이상에서 24시간동안 추출하였다. 추출물을 용해군과 불용해군으로 분리하기 위하여 여과하고 당도 20 brix가 될 때까지 농축하였다. 이후 하기 표 1과 같은 비율로 식품첨가물을 첨가하고 진공 동결 건조하였다. 마지막으로 건조가 끝나면 분쇄하여 칼슘흡수 보조제를 완성하였다.As shown in FIG. 1, the present inventors dried and crushed Hokkaeng maternal acupuncture and then added lactic acid solution corresponding to 20 times of purified water and dry matter 0.02% (w / w) of raw materials for 24 hours at 90 ° C or higher. Extracted during. The extract was filtered to separate the soluble and insoluble groups and concentrated until the sugar content reached 20 brix. Thereafter, the food additive was added in the same ratio as in Table 1 and vacuum lyophilized. Finally, after drying, it was ground to complete a calcium absorption aid.
<실시예 2> 칼슘흡수 보조제의 효과 테스트Example 2 Effect Test of Calcium Absorption Adjuvant
본 발명자들은 상기 실시예 1에서 제조한 칼슘흡수 보조제를 암컷 흰쥐를 통하여 그 효과를 검증하였다. 구체적으로, 4주령의 암컷흰쥐(Spargue-Dawley female rat) 24마리를 대상으로 표 2에 기재된 바와 같이 대조군으로 일반조제사료를 섭취한 C군, 실험군으로 일반조제사료에 패각칼슘과 아쿠아칼슘을 동량으로 혼합하여 사료조성에 0.5%가 되도록 첨가한 CC군, 일반조제사료에 모자반 칼슘흡수 보조제 1%를 첨가한 CS군, 일반조제사료에 모자반 칼슘흡수 보조제 1%와 패각칼슘과 아쿠아칼슘을 동량으로 혼합하여 0.5% 첨가한 CSC군으로 나누어 4주 동안 사육한 후, 사료섭취량, 체중증가량, 뼈의 밀도, 강도, 성장정도를 측정하였다.The present inventors verified the effect of the calcium absorption aid prepared in Example 1 through female rats. Specifically, in the four-week-old Spargue-Dawley female rats, as shown in Table 2, the group C, which received the general formula as a control group, the same amount of shell calcium and aqua calcium in the general formula as the experimental group CC group added 0.5% to feed composition, CS group added 1% maternal calcium absorption aid to general food preparation, 1% maternal calcium absorption aid and shell calcium and aqua calcium The mixture was divided into 0.5% CSC group, and reared for 4 weeks. Feed intake, weight gain, bone density, strength, and growth were measured.
그 결과 사료의 섭취량은 표 3, 체중증가량은 표 4로 각각 나타내었다. 사료섭취량은 4주 동안 모든 군 간의 유의적인 차이(p<0.05)가 없어 대조군과 비교시 사료기피 현상은 나타나지 않았다. 체중증가량은 3주차에 CSC군이 유의적으로 낮았으나 총체중증가량은 유의적인 차이(p<0.05)가 나타나지 않았다.As a result, the intake of feed is shown in Table 3, and the weight gain is shown in Table 4, respectively. Feed intake was not significantly different among all groups (p <0.05) for 4 weeks. Body weight gain was significantly lower in CSC group at 3 weeks, but total weight gain was not significantly different (p <0.05).
Weaned 3wk female rats were randomized to a Control group, a Control+CaCO3 0.5% group,Weaned 3wk female rats were randomized to a Control group, a Control + CaCO 3 0.5% group,
a Control+Sargassum EX. 1% group, a Control+Sargassum EX.1%+CaCO3 0.5% group.a Control + Sargassum EX. 1% group, a Control + Sargassum EX.1% + CaCO 3 0.5% group.
1)Not significantly(p<0.05) 1) Not significantly (p <0.05)
1)Not significantly(p<0.05) 1) Not significantly (p <0.05)
2)Values within column with different superscript letters are significantly different at p<0.05. 2) Values within column with different superscript letters are significantly different at p <0.05.
뼈의 밀도, 강도, 성장정도는 표 5 및 표 6으로 나타내었다. 뼈의 성장을 나타내는 뼈의 습중량(wet weight), 길이, 직경 모두 군간의 유의적인 차이가 나타나지 않았다. 뼈의 밀도와 강도에서 패각칼슘과 아쿠아칼슘 혼합 첨가군인 CC군, CSC군은 대조군보다 높게 나타났으나 통계적인 차이는 없는 것으로 나타났다. 하지만, 모자반 칼슘흡수 보조제 첨가 CS군은 대조군보다 유의적으로 높게 나타났는데, 이는 모자반 칼슘흡수 보조제가 흰쥐의 칼슘흡수율을 높여 뼈성장에 도움을 준 결과로 사료된다.Bone density, strength, and growth are shown in Tables 5 and 6. Wet weight, length, and diameter of the bones, indicating bone growth, did not show any significant differences between the groups. In the density and strength of bones, the CC and CSC groups, which were mixed with shell calcium and aqua calcium, were higher than the control group, but there was no statistical difference. However, CS group with mother calcium absorption aid was significantly higher than control group, which is considered to be the result of calcium calcium absorption aid in rats to help bone growth.
Values within column with different superscript letters are significantly different at p<0.05.Values within column with different superscript letters are significantly different at p <0.05.
1)Not significantly 1) Not significantly
1)bone mineral density(뼈 미네랄 밀도), 1) bone mineral density,
2)bone mineral contents(뼈 미네랄 양) 2) bone mineral contents
3)Values within column with different superscript letters are significantly different at p<0.05. 3) Values within column with different superscript letters are significantly different at p <0.05.
<실시예 3> 칼슘흡수 보조제를 기능성 식품의 제조Example 3 Preparation of Functional Foods of Calcium Absorption Aids
본 발명자들은 상기 실시예를 통해 모자반 추출물이 칼슘흡수 보조제로서의 효능이 뛰어남을 확인하여 이를 유효성분으로 함유하는 다양한 건강식품으로 사용될 수 있는 기능성 식품을 하기와 같이 제조하였다.The inventors have confirmed that the Mabanban extract excellent efficacy as a calcium absorption aid through the above embodiment to prepare a functional food that can be used as a variety of health foods containing it as an active ingredient as follows.
<3-1> 요구르트의 제조<3-1> Preparation of Yogurt
본 발명자들은 상기 실시예 1에서 제조한 칼슘흡수 보조제를 이용한 요구르트를 제조하였다. 구체적으로, 우유를 85℃에서 30분 동안 살균한 후 모자반 칼슘흡수 보조제를 각각 0%, 0.1%, 0.5%, 1%로 첨가하고 요구르트 혼합종균을 넣어 요구르트 제조과정(숙성)중의 pH, 적정산도, 젖산균수의 변화를 측정하고 완제품의 관능검사를 실시하였다.The present inventors prepared yogurt using the calcium absorption aid prepared in Example 1. Specifically, the milk is sterilized at 85 ° C. for 30 minutes, and then the mother calcium absorption aid is added at 0%, 0.1%, 0.5%, and 1%, respectively, and the yogurt mixing spawn is added to the pH and titratable acidity during the yogurt manufacturing process (maturation). The changes in the number of lactic acid bacteria were measured and sensory evaluation of the finished product was performed.
요구르트는 일반적으로 젖산균주의 활동으로 숙성이 진행되면서 pH가 낮아지고 적정산도가 증가하게 된다. 모자반 칼슘흡수 보조제 첨가 요구르트의 pH와 적정산도의 변화는 도 2 및 도 3에 기재하였다. pH의 경우 0시간째 무첨가군과 첨가군의 pH는 6.50~6.66사이로 비슷하였지만, 2시간째부터 0.5% 첨가군, 1% 첨가군의 pH 변화는 각각 6.56에서 5.19, 6.50에서 5.10으로 0%첨가군 pH 변화 6.66에서 6.59보다 크게 낮아졌으며, 0.1% 첨가군 또한 4시간째부터 pH 5.07로 크게 낮아졌다. 모자반 칼슘흡수 보조제 첨가군의 2~4시간째 pH 5.07~5.19는 0%첨가군 12시간째 pH 5.47보다 낮은 것으로 나타났다. 적정산도 역시 0시간째 1.25~1.62% 사이로 비슷하였지만 2시간째부터 0.5% 첨가군, 1% 첨가군에서 각각 1.41%에서 4.83%, 1.62%에서 5.25%로 0% 첨가군 1.25%에서 1.46%보다 크게 높아진 것으로 나타났다. 0.1% 첨가군은 4시간째부터 4.88%로 크게 높아졌으며 첨가군의 2~4시간째 적정산도 4.83~5.25%는 0% 첨가군 12시간째 적정산도 3.92보다 높은 것으로 나타났다.Yogurt generally has a low pH and an appropriate acidity as it matures due to lactic acid strain activity. Changes in pH and titratable acidity of yogurt with mother calcium absorption aid were shown in FIGS. 2 and 3. In the case of pH, the pH of the no-added group and the added group was similar between 6.50 and 6.66 at 0 hours, but the pH change of 0.5% and 1% added groups was increased from 6.56 to 5.19 and from 6.50 to 5.10 at 0%, respectively. Group pH change was significantly lower than 6.59 at 6.66, and 0.1% addition group was also significantly lowered to pH 5.07 from 4 hours. The pH 5.07-5.19 at 2-4 hours of the mother calcium absorption aid supplement group was lower than the pH 5.47 at 12 hours of the 0% addition group. The titratable acidity was similar between 1.25 ~ 1.62% at 0 hours, but from 1.41% to 4.83% and 1.62% to 5.25% at 0.5% and 1%, respectively, from 0% and 1.25% to 1.46% at 2 hours. Significantly higher. The 0.1% addition group was significantly increased from 4 hours to 4.88%, and the titratable acidity of 4.83 ~ 5.25% was higher than 3.92 at 12 hours of 0% addition group.
젖산균수의 변화는 도 4로 나타내었으며 초기균수는 0.97 × 107 ~ 1.07 × 107 CFU/㎖로 비슷하였으나 2시간째 0.5%, 1% 첨가군이 3.30 × 108 CFU/㎖, 4.40 × 108 CFU/㎖로 0% 첨가군 0.93 × 108 CFU/㎖ 보다 크게 늘어났다. 0.1% 첨가군은 4시간째부터 크게 늘어났다. 0% 첨가군의 경우 10시간째부터 5.90 × 107 CFU/㎖로 많이 낮아진 반면 모자반 칼슘흡수 보조제 첨가군은 1.30 × 108 ~ 3.80 × 108 CFU/㎖ 사이로 균수가 유지되는 것으로 나타났다.The change in the number of lactic acid bacteria was shown in FIG. 4, and the initial bacterial count was similar to 0.97 × 10 7 ~ 1.07 × 10 7 CFU / mL, but 0.5% and 1% added groups were added 3.30 × 10 8 CFU / mL and 4.40 × 10 at 2 hours. At 8 CFU / mL, it was significantly increased than the 0% addition group 0.93 × 10 8 CFU / mL. The 0.1% addition group greatly increased from 4 hours. The 0% added group was significantly lowered to 5.90 × 10 7 CFU / mL from 10 hours, while the calcium calcium adjuvant supplemented group was maintained between 1.30 × 10 8 and 3.80 × 10 8 CFU / mL.
위의 결과를 종합해볼 때 모자반 칼슘흡수 보조제를 첨가할 경우 젖산균주의 증식을 활발하게 하여 숙성시간이 단축되는 것으로 나타났다.Based on the above results, the addition of mother calcium supplemental adjuvant showed that the growth time of lactic acid strain was increased and the aging time was shortened.
<3-2> 식빵의 제조<3-2> Production of bread
본 발명자들은 상기 실시예 1에서 제조한 칼슘흡수 보조제를 이용한 식빵을 제조하였다. 구체적으로, 식빵믹스에 모자반 칼슘흡수 보조제를 각각 0%, 0.5%, 1%, 2% 로 첨가한 후 제빵기를 사용하여 식빵을 제조한 후 빵의 크기를 살펴본 결과 표 7, 도 5와 같다. 동량의 물, 동량의 재료량, 같은 둘레의 틀을 사용하였기 때문에 빵의 둘레와 무게는 첨가량에 의존하지 않고 비슷하였다. 하지만, 길이는 첨가량에 따라 점차 증가하였는데 이는 모자반 칼슘흡수 보조제가 이스트의 숙성에 긍정적인 영향을 주어 빵의 크기가 증가한 것으로 사료된다.The present inventors prepared a bread using a calcium absorption aid prepared in Example 1. Specifically, after adding the mother calcium absorption aid to the
<3-3> 음료의 제조<3-3> Preparation of Beverage
꿀 522 ㎎522 mg of honey
치옥토산아미드 5 ㎎
니코틴산아미드 10 ㎎
염산리보플라빈나트륨 3 ㎎
염산피리독신 2 ㎎
이노시톨 30 ㎎
오르트산 50 ㎎Orthoic acid 50 mg
칼슘흡수 보조제 4.8 ∼ 12.8 ㎎Calcium Absorption Aid 4.8-12.8 mg
물 200 ㎖200 ml of water
상기 조성 및 함량으로 하여 통상적인 방법을 사용하여 음료를 제조하였다.With the above composition and content, drinks were prepared using conventional methods.
<3-4> 츄잉껌의 제조<3-4> Preparation of Chewing Gum
껌베이스 20 질량부(w/w)20 parts by mass of gum base (w / w)
설탕 76.36 ∼ 76.76 질량부76.36 to 76.76 parts by weight of sugar
칼슘흡수 보조제 2.4 ∼ 6.4 질량부Calcium absorption aids 2.4 to 6.4 parts by mass
후르츠향 1 질량부1 part by mass of fruit
물 2 질량부2 parts by mass of water
상기 조성 및 함량으로 하여 통상적인 방법을 사용하여 츄잉껌을 제조하였다.Chewing gum was prepared using conventional methods using the above composition and content.
<3-5> 캔디의 제조<3-5> Preparation of Candy
설탕 50 ∼ 60 질량부(w/w)50 to 60 parts by mass of sugar (w / w)
물엿 39.26 ∼ 49.66 질량부Starch syrup 39.26-49.66 parts by mass
칼슘흡수 보조제 2.4 ∼ 6.4 질량부Calcium absorption aids 2.4 to 6.4 parts by mass
오렌지향 0.1 질량부0.1 parts by mass of orange flavor
상기 조성 및 함량으로 하여 통상적인 방법을 사용하여 캔디를 제조하였다.Candy was prepared using conventional methods with the above composition and content.
<3-6> 비스켓의 제조<3-6> Preparation of Biscuits
박력1급 88 ㎏
중력1급 76.4 ㎏Gravity First Class 76.4 ㎏
정백당 16.5 ㎏16.5 kg per white
식염 2.5 ㎏2.5 kg of salt
포도당 2.7 ㎏2.7 kg of glucose
팜쇼트닝 40.5 ㎏Palm shortening 40.5 kg
암모 5.3 ㎏5.3 kg of ammo
중조 0.6 ㎏Medium kg 0.6 kg
중아황산나트륨 0.55 ㎏0.55 kg sodium bisulfite
쌀가루 5.0 ㎏Rice flour 5.0 kg
비타민 B1 0.003 ㎏Vitamin B1 0.003 kg
비타민 B2 0.003 ㎏0.003 kg of vitamin B2
밀크향 0.16 ㎏Milk Flavor 0.16 ㎏
물 71.1 ㎏71.1 kg of water
전지분유 4 ㎏
대용분유 1 ㎏Substitute
제일인산칼슘 0.1 ㎏0.1 kg of calcium phosphate
살포염 1 ㎏Spray
분무유 25 ㎏25 kg of spray oil
칼슘흡수 보조제 0.5 ∼ 5 ㎏Calcium Absorption Aid 0.5 ~ 5 ㎏
상기 조성 및 함량으로 하여 통상적인 방법을 사용하여 비스켓을 제조하였다.Biscuits were prepared using conventional methods with the above composition and content.
<3-7> 아이스크림의 제조<3-7> Preparation of Ice Cream
유지방 10.0 질량부(w/w)Milk fat 10.0 parts by mass (w / w)
무지유고형분 10.8 질량부10.8 parts by mass of non-fat solids
설탕 12.0 질량부12.0 parts by mass of sugar
물엿 3.0 질량부Starch syrup 3.0 parts by mass
유화안정제(스팬,span) 0.5 질량부0.5 parts by mass of emulsion stabilizer (span, span)
향료(스트로베리) 0.15 질량부0.15 parts by mass of flavor (strawberry)
물 63.31 ∼ 62.91 질량부63.31 to 62.91 parts by mass of water
칼슘흡수 보조제 2.4 ∼ 6.4 질량부Calcium absorption aids 2.4 to 6.4 parts by mass
상기 조성 및 함량으로 하여 통상적인 방법을 사용하여 아이스크림을 제조하였다.Ice cream was prepared using conventional methods using the above composition and content.
<3-8> 쵸코렛의 제조<3-8> Preparation of Chocolate
설탕 34.36 ∼ 34.76 질량부(w/w)34.36 to 34.76 parts by weight of sugar (w / w)
코코아 버터 34 질량부34 parts by mass of cocoa butter
코코아 매스 15 질량부15 parts by mass of cocoa mass
코코아 파우다 15 질량부15 parts by mass of cocoa powder
레시틴 0.5 질량부0.5 part by mass of lecithin
바닐라향 0.5 질량부0.5 part by mass of vanilla
칼슘흡수 보조제 2.4 ∼ 6.4 질량부Calcium absorption aids 2.4 to 6.4 parts by mass
상기 조성 및 함량으로 하여 통상적인 방법을 사용하여 초코렛을 제조하였다.With the above composition and content, chocolate was prepared using conventional methods.
도 1은 본 발명의 칼슘흡수 보조제 제조방법을 단계별로 표시한 것이고, 1 is a step-by-step display of the calcium absorption aid preparation method of the present invention,
도 2는 발효 동안에 본 발명의 0 내지 1%의 모자반 추출물이 첨가된 요구르트 pH의 변화를 나타낸 그래프이고, 2 is a graph showing the change of yogurt pH added 0-1% of Mabban extract of the present invention during fermentation,
도 3은 발효 동안에 본 발명의 0 내지 1%의 모자반 추출물이 첨가된 요구르트의 적정된 산성도의 변화를 나타낸 그래프이고, Figure 3 is a graph showing the change in the titrated acidity of yogurt added 0-1% of Mabban extract of the present invention during fermentation,
도 4는 발효 동안에 본 발명의 0 내지 1%의 모자반 추출물이 첨가된 요구르트의 살아있는 세포수의 변화를 나타낸 그래프이고, Figure 4 is a graph showing the change in viable cell number of yogurt added 0-1% of Mabban extract of the present invention during fermentation,
도 5는 모자반 칼슘흡수 보조제를 첨가한 식빵의 사진이다. 5 is a photograph of a bread to which the mother calcium absorption aid was added.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070111471A KR100899556B1 (en) | 2007-11-02 | 2007-11-02 | Functional Foods Adding Sargassum spp. Extracts |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070111471A KR100899556B1 (en) | 2007-11-02 | 2007-11-02 | Functional Foods Adding Sargassum spp. Extracts |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20090045578A KR20090045578A (en) | 2009-05-08 |
KR100899556B1 true KR100899556B1 (en) | 2009-05-26 |
Family
ID=40855663
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020070111471A KR100899556B1 (en) | 2007-11-02 | 2007-11-02 | Functional Foods Adding Sargassum spp. Extracts |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100899556B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230149161A (en) | 2022-04-19 | 2023-10-26 | 전남대학교산학협력단 | Tea manufacturing method using Sargussum Horneri extract. |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200144016A (en) | 2019-06-17 | 2020-12-28 | 전남대학교산학협력단 | Compositions for Alleviating Gluten-Sensitive Symptoms Comprising Extract of Sargassum Fulvellum and Methods for Producing the Same |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020068823A (en) * | 2001-02-23 | 2002-08-28 | 대한민국(관리부서:국립수산과학원) | Seaweed beverage mixed brown algae mold of green color and its processing knowhow |
KR100386086B1 (en) | 2000-10-27 | 2003-06-02 | 김병수 | A Healthful Food Using the Extract of Seaweeds and a Preparing Method Thereof |
JP3749978B2 (en) * | 2001-07-11 | 2006-03-01 | 静岡県 | Bone formation enhancing composition exhibiting anti-osteoporosis effect |
KR100768445B1 (en) | 2006-10-31 | 2007-10-18 | 부경대학교 산학협력단 | Process of the bread using an sargassum tortile extract |
-
2007
- 2007-11-02 KR KR1020070111471A patent/KR100899556B1/en active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100386086B1 (en) | 2000-10-27 | 2003-06-02 | 김병수 | A Healthful Food Using the Extract of Seaweeds and a Preparing Method Thereof |
KR20020068823A (en) * | 2001-02-23 | 2002-08-28 | 대한민국(관리부서:국립수산과학원) | Seaweed beverage mixed brown algae mold of green color and its processing knowhow |
JP3749978B2 (en) * | 2001-07-11 | 2006-03-01 | 静岡県 | Bone formation enhancing composition exhibiting anti-osteoporosis effect |
KR100768445B1 (en) | 2006-10-31 | 2007-10-18 | 부경대학교 산학협력단 | Process of the bread using an sargassum tortile extract |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230149161A (en) | 2022-04-19 | 2023-10-26 | 전남대학교산학협력단 | Tea manufacturing method using Sargussum Horneri extract. |
Also Published As
Publication number | Publication date |
---|---|
KR20090045578A (en) | 2009-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104287049A (en) | Meal replacement protein powder solid beverage for managing body weight | |
US20040253227A1 (en) | Perioperative multivitamin protein beverage and additive for use in preparing an individual for fast surgical recovery | |
EP1913943B1 (en) | Prophylactic or therapeutic composition for hemoglobinuria or myoglobinuria | |
KR101539382B1 (en) | Food composition for improvement of bowel function and relief of constipation | |
JPH09191852A (en) | Healthy food | |
CN107232471A (en) | A kind of nutrient solid beverage | |
KR100647067B1 (en) | Feed composition comprising Rubus coreanus for poultry and the egg produced by feeding the same | |
KR20110119305A (en) | A functional beverage comprising taurine, royal jelly, red ginseng, lycii fructus, glumate and apple essence as main ingredients | |
CN112889924A (en) | Milk tablet for preventing dental caries and its preparation method | |
CN108308621A (en) | A kind of weight losing meal-replacing powder rich in rice oligopeptide | |
KR101930433B1 (en) | manufacturing method of sweet jelly containing mealworm and sweet jelly containing mealworm made by the same | |
KR100899556B1 (en) | Functional Foods Adding Sargassum spp. Extracts | |
KR101902313B1 (en) | Composition of baby food and nourishing food for pet | |
JPH1189539A (en) | Food, drink, feed and chinese medicine material containing leaf, stem and branch of stevia plant | |
US20030119910A1 (en) | Therapeutic or preventing agent for diseases caused by decrease in the expression level of klotho protein | |
CN105795149A (en) | Piglet milk powder with high nutrition and high absorbability and preparation method thereof | |
JPWO2004084919A1 (en) | Food for pathological improvement that reduces the concentration of low molecular weight nitrogen-containing compounds in the blood | |
KR100915596B1 (en) | Preparation Method of Assistance Material for Calcium Assimilation Containing Sargassum spp. Extracts as Essential Ingredient | |
CN112655802A (en) | Calcium gel candy and preparation process thereof | |
KR101322282B1 (en) | Composition for bone growth promotion comprising Gelatin hydrolysates | |
CN115886171B (en) | Composite solid beverage and preparation method thereof | |
CN111296827A (en) | Composition and application thereof | |
KR20190113721A (en) | Onion Coat composition Using An Enzyme With Stevia Extract And Method thereof | |
KR20200138472A (en) | Composition for relieving hangover comprising allium hookeri extract and fish collagen | |
RU2579215C1 (en) | Dry mixture for beverage preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130510 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20140509 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20160504 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20170519 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20180515 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20190520 Year of fee payment: 11 |